Over a billion people suffer from diseases that impact the back of their eyes. Advanced opthalmic imaging open new avenues to better diagnose and treat these pathologies.
Imagine Eyes’ solutions enable examining patients’ retinas with an unprecedented level of detail – the cellular level – thanks to adaptive optics technology.
Adaptive optics lets you see what conventional retinal imaging cannot: damage at the level of individual cells, vascular wall remodeling, and other subclinical microlesions – directly in patients’ retinas.
For clinical research and retinal therapy development, this means new discoveries in disease mechanisms, and highly sensitive cellular biomarkers to de-risk and accelerate development programs.
Cellular-level assessments for clinical research and trials
rtx1™ – the world’s most widely used adaptive optics imaging device
Latest news
Upcoming events
https://www.imagine-eyes.com/wp-content/uploads/denver-2228783_1920.jpg
1440
1920
contrib
https://www.imagine-eyes.com/wp-content/uploads/logo.svg
contrib2026-04-14 12:16:342026-04-20 16:11:18ARVO 2026Replay videos
Ultrahigh resolution
Detect microscopic lesions. Track minute changes in the retina
Cellular biomarkers
Examine individual retinal cells including cone photoreceptors
Microvascular biomarkers
Assess the wall structure of small retinal blood vessels
For clinical research
Quick procedures for patients and workflows
Imagine Eyes
18 rue Charles de Gaulle
91400 Orsay – France





Non-neovascular AMD: update on candidate AO biomarkers
Regenerative retinal therapy evaluated with adaptive optics imaging
Early atrophic changes in AMD captured by rtx1
Cone cells before/after macular hole surgery
Photoreceptor changes in diabetes: new findings published